SABBY 13G OTLK 5.22.19

Company

Outlook Therapeutics, Inc.

Filed

May 22, 2019

Accession Number

0001535610-19-000086

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →